Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,060 INR | +0.31% | +2.51% | +24.19% |
Apr. 29 | Glenmark Pharmaceuticals Gets US FDA's Final Approval for Generic Pain Relief Medicines | MT |
Apr. 25 | Glenmark Lifesciences' Net Profit Slides in Fiscal Q4 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.19% | 3.57B | |
+20.61% | 43.18B | |
+20.67% | 22.59B | |
+14.56% | 14.56B | |
+13.94% | 13.54B | |
+43.35% | 11.5B | |
-8.37% | 6.93B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.36B |
- Stock Market
- Equities
- GLENMARK Stock
- News Glenmark Pharmaceuticals Limited
- Glenmark Pharmaceuticals : S&P Global Maintains Glenmark Pharmaceuticals' BB- Issuer Credit Rating; Outlook Stable